Beckman Coulter Posts 9 Percent Revenue Growth for Q3 | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Beckman Coulter reported after the close of the market Wednesday that its third-quarter revenues increased 9 percent, with a decline in its Life Sciences segment offset by growth in the Clinical Diagnostics segment.

The Orange County, Calif.-based firm brought in total revenues of $893.8 million for the three-month period ended Sept. 30, compared to $822.8 million for the third quarter of 2009. Beckman beat analysts' consensus estimate of $884.7 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genetic history of HIV in the US, and more.

There are a few projects aimed at addressing the lack of diversity in genomic research, Technology Review reports.

A national assessment shows that US students lag in the sciences, but suggests that achievement gaps are narrowing.

Harvard's George Church discusses HGP-write with the Journal of the American Medical Association.